Erntell M, Skoog G, Cars O, Eriksson M, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P. STRAMA, Swedish Institute.

Slides:



Advertisements
Similar presentations
European Centre for Disease Prevention and Control
Advertisements

Antibiotic policy to prevent resistance development Inga Odenholt Associate professor Department of Infectious Diseases, Malmö Lund University, Sweden.
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious.
When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.
+ A Vitamin T Overdose? : An audit of piperacillin/ tazobactam use at Royal Perth Hospital Amelia Davis and Matthew Hanson Contributors: Dr Susan Benson,
 Cefixime is quickly establishing in Western countries as a potent broad-spectrum antibiotic with a variety of indications. A multinational, nonrandomized.
Pneumonia & Respiratory Tract Infection: Antibiotic risk for Clostridium difficile Kieran Hand*, Adil Ahmed †, Adriana Basarab ¶, Whitney Chow †, Nick.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
Use of antibiotics. Antibiotic use Antimicrobials are the 2 nd most common drugs prescribed by office based physicians In USA1992: 110 million oral antimicrobial.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
RESPIRATORY TRACT INFECTIONS: ANTIBIOTIC PRESCRIBING
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
Antibiotic Prescribing Practices of Primary Care Prescribers for Acute Respiratory Tract Infections and Diarrhoea in New Delhi, India Anita Kotwani 1,
Improving Antibiotic use through a Nationwide Decentralized Project – A Nine-Year Experience Cars O, Stålsby Lundborg C, Mölstad S Swedish Strategic Programme.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
Journal of the Pediatric Infectious Diseases Society Advance Access published June 2, 2014.
Urinary Tract Infections in Children Prof. Pushpa Raj Sharma.
Kh Sadique Faisal Asst. Lecturer Northern University Bangladesh.
THERAPY FOR ANAEROBIC INFECTIONS  Tissue necrosis and abscess formation are often seen in anaerobic infections.  Drainage and debridement together with.
Medications for the Treatment of Infections. Antibiotic vs. Antibacterial Used interchangeably Origin of antibiotic includes any antimicrobial agent Antibacterial.
Streptococcus pyogenes Team Case Study 2. The Diagnosis Ben Fallerez is a 12 year old boy going to school in France. He complained of a sore throat. The.
Incidence of hospitalisations in both groups Incidence of documented infections Abstract Problem statement: Patients on cancer chemotherapy are at substantial.
Bacterial Pneumonia.
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Methodological challenges for AMR surveillance programmes Gous AGS, Pochee E School of Pharmacy Medical University of Southern Africa.
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
DISCHARGE DEVELOPMENTS ACROSS NORTH GLASGOW OUTPATIENT AND HOME PARENTERAL ANTIBIOTIC THERAPY (OHPAT) SERVICE Lindsay Semple Project Manager/Nurse Specialist.
The Rational Use of Antibiotics
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
Swedish TV-production on Antibiotic Resistance Financially supported by the EU commission.
ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2.
Antimicrobials - Quinolones & Fluoroquinolones Antimicrobials - Quinolones & Fluoroquinolones Pharmacology -1 DSX 215 DSX 215 Dr/ Abdulaziz Saeedan Pharmacy.
ANTIBIOTIC USE IN PATIENTS WITH FEVER OF UNKNOWN ORIGIN (FUO) AT PANTI RAPIH HOSPITAL YOGYAKARTA-INDONESIA Hartayu T 1, Asdie HAH 2, Suryawati S 3 1 Faculty.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious.
Prevalence of Bacteremia in Low Risk Patients with Sickle Cell Disease and Fever Shashidhar Marneni, MD Fellow(1 st Year) Pediatric Emergency Medicine.
Tigecycline use in serious nosocomial infections: a drug use evaluation Matteo Bassetti*, Laura Nicolini, Ernestina Repetto, Elda Righi, Valerio Del Bono,
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
Antibiotics (anti-microbials)
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 07- Penicillins.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
The AHRQ Safety Program for Improving Antibiotic Use
Antibiotic use and bacterial complications following upper respiratory tract infections: a population based study.
Antibiotics: handle with care!
Antibiotics: handle with care!
Number of S, I and R to six antibiotics
Use of antibiotics.
Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.
The AHRQ Safety Program for Improving Antibiotic Use
Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy Tomasz Ozorowski, M.D. University of Medical.
The AHRQ Safety Program for Improving Antibiotic Use
ECDC-EMEA Joint Technical Report Part I: Trends and burden of antimicrobial resistance in the European Union Zsuzsanna Jakab, Director European Centre.
Dr Asmaa fathy abdellah hassan
Hospital acquired infections/ Nosocomial infections
Clint Rohner, PharmD EIRMC Clinical Coordinator, former AMP lead
Valley Fever (Coccidioidomycosis) Incidence of Valley Fever in the US.
Hospital Antibiotic Stewardship Programs
Jessina C. McGregor, PhD; Miriam R. Elman, MPH; David T
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Improving Antibiotic use through a Nationwide Decentralized Project –
Impact of Microbial Culture Analysis and Prophylactic use of Antibiotics in Acute Severe Pancreatitis Jagadish babu Dasari, Cristiano Ialongo, Aruna Chandranath.
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
INFECTIOUS DISEASES CLERKSHIP –
Endocarditis is an inflammation of the endocardium, the membrane lining the chambers of the heart and covering the cusps of the heart valves. Infective.
AHRQ Safety Program for Improving Antibiotic Use
Presentation transcript:

Erntell M, Skoog G, Cars O, Eriksson M, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P. STRAMA, Swedish Institute for Infectious Disease Control, S Solna, Sweden POINT PREVALENCE STUDY OF ANTIBIOTIC USE IN HOSPITALISED PEDIATRIC PATIENTS IN SWEDEN Introduction and purpose Data revealing antibiotic consumption and prescription patterns related to diagnose at the patient level is essential in finding ways to optimize antibiotic use in the hospital setting. We present data on pediatric patients from the first nation wide point prevalence study, PPS, performed in Sweden. Methods The study was performed within a two-week period in November 2003 by the local STRAMA-groups using a web-based reporting system. Each department had one personal visit of an experienced doctor collecting data. The protocol was designed to present demographic data as well as the amounts and indications for antimicrobial agents against bacteria and fungi. Treatments were recorded in relation to diagnose and the therapeutic indication as either prophylactic use or treatment of community acquired (CAI) and hospital acquired infection (HAI). 19 pre-defined diagnosis groups were used. Children were defined as patients 0-16 years old. Results 28 out of 54 hospitals participating in the main study recorded data on 913 admitted children. Four pediatric departments at university hospitals included nearly 50% of the patients included children (141 girls, 125 boys) 279 different therapies were recorded; 251 in departments of pediatrics (28%) 28 in wards for adults 29% were related to immunosuppression and foreign material infections. Cultures were taken before oral treatment in 68% and before parenteral treatment in 73%. The distribution of diagnosis groups and therapy reasons in treated children: The antimicrobials used in 258 treatments for CAI and HAI were: Antimicrobials used for treatment of three community acquired infections (CAI): Antimicrobials used in 47 septicaemia treatments: The length of peri-operative prophylaxis was too long, >1 day, in 59% of all therapies. 86% of all treatments were assessed as adequate. Conclusions The PPS method was successfully introduced resulting in one of the largest surveys in Europe of antimicrobial hospital treatments in children. 86% of treatments were adequate Peri-operative prophylaxis was too long, >1 day in 59% of therapies The HAI prevalens was 7% Cephalosporins are over-used in community acquired infections as pneumonia and skin and soft tissue infections 29% of the therapies were complicated by immunosuppression and/or foreign material Cultures were taken in 68% before oral treatment and 73% before parenteral treatment Abstract Objectives: The objective of the study was to introduce a nation wide survey system for frequent assessment of the use of antimicrobial agents in relation to diagnose. The STRAMA-groups have performed the first point prevalence study, PPS, using a web-based reporting system. Method: A nation wide PPS with one personal visit to each department was performed within a two-week period in November The protocol was designed to present demographic data as well as the amounts and indications for antimicrobial agents against bacteria and fungi. Treatments were recorded in relation to diagnoses and prophylactic use, community acquired (CAI) and hospital acquired infection (HAI). 19 pre- defined diagnosis groups were used. Children were identified as patients 0-16 years old. Results: 28 out of the 54 participating hospitals in the main study recorded data for children. Four pediatric departments at university hospitals included nearly 50% of the patients. 266 children (125 girls, 141 boys) were treated with antimicrobial agents and 27 of them were admitted to wards for adults. The children were given 279 different therapies and 29% of these were related to immunosuppression and foreign material or both. In departments of pediatrics 252 (28%) patients were treated with antimicrobials. The distribution of the 279 therapies was; community acquired infections in 52%, hospital-acquired infections in 23% and prophylaxis in 25%. The most common diagnose groups were; primary septicaemia 47 (17%), pulmonary infections 42 (15%), upper urinary tract infection 26 (9%), lower gastrointestinal tract 25 (9%) and skin and soft tissue infections 24 (9%). 340 different antimicrobials were used, 258 for treatment and 82 for prophylaxis. The most commonly used antimicrobials were: in treatment, cephalosporins 106 (41%), beta-lactamase sensitive penicillins 22 (9 %), tienamycins 19 (7%), glycopeptides 17 (7%). In prophylaxis, the order of use was cephalosporins 25 (30%), co-trimoxazole 13 (16%), beta-lactamase resistant penicillins 12 (15%) and beta-lactamase sensitive penicillins 6 (7%). More than 90% of treatments were assessed as adequate. The length of prophylaxis was too long, more than one day, in nearly 50% of al perioperative prophylactic treatments. Conclusions: The PPS method was successfully introduced resulting in one of the largest surveys in Europe of antimicrobial hospital treatments in children. The study indicates that hospitalised children in Sweden are treated for serious infections. But still, the use of cephalosporins is too predominating. Perioperative prophylaxis is too long, as in adults. Diagnose groups Central nervous system Ophthalmic infections Mouth and throat Upper respiratory tract Bronchitis Pulmonary infections Cardiovascular system Upper gastrointestinal tract Lower gastrointestinal tract Infectious gastrointestinal diseases Liver/bile duct/pancreas/spleen Skin and soft tissue Bone and joint Lower urinary tract infection Upper urinary tract infection Genital infections Septicaemia, primary Un-specified indication, fever Indication unclear Antimicrobials used in 82 therapies as prophylaxis (%): peri-operative (49) medical (33) Cephalosporins Isoxa-pc 22 3 Nitroimidazoles 12 3 Beta-lact sens pc 4 12 Co-trimoxazole 2 36 Trimetoprim 2 12 The therapy reason for treatment was: CAI in 52%, 14% of all admitted HAI in 23%, 7% of all admitted Prophylaxis in 25%, 7% of all admitted